Spatio-temporal integration of skin inflammation
The project aims to elucidate spatio-temporal inflammasome signaling in keratinocytes to identify new therapeutic targets for inflammatory skin disorders like atopic dermatitis and psoriasis.
Projectdetails
Introduction
To ‘feel comfortable in one’s own skin’ is an idiom referring to one’s confidence in interacting with others. However, when the skin is inflamed, as in atopic dermatitis or psoriasis, patients carry a substantial burden leading to opposite effects. Current therapies target redundant, late-stage inflammatory events but not the disease drivers, leading to heterogeneous and insufficient efficacy. Understanding the proximal mechanisms of inflammation will stimulate the development of better therapies.
Background
Among the innate immune sensors for stress and microbes in keratinocytes, mutations in the NLRP1 and NLRP10 inflammasomes are linked to skin disorders. These molecules and the pro- and anti-inflammatory IL-1 family members they regulate are differentially expressed in the different layers of the epidermis.
We hypothesize that inflammasome signaling in keratinocytes needs context-dependent and spatio-temporal control to avoid inflammation, which poses unique analytical and conceptual challenges.
Objectives
Therefore, to understand how inflammasome signaling in specific keratinocytes drives skin inflammation, 4D-SkINFLAM will:
- Optogenetically activate specific inflammasome components with spatio-temporal precision and perform a spatial analysis of transcriptomes and proteomes in neighboring cells.
- Define the ‘sensome’ and the activity of inflammasomes in different areas of the epidermis using loss-of-function approaches and pathway activity reporters.
- Evaluate how spatial inflammasome activity drives skin inflammation using mouse models.
- Discover spatial inflammasome activation and its effects in inflammatory skin disorders through AI-driven deep visual proteomics combined with an analysis of inflammasome activity.
Conclusion
A precise understanding of spatio-temporal inflammasome signaling in the skin will be critical for selecting therapeutic targets acting as upstream drivers of prevalent diseases with high unmet needs.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.188 |
Totale projectbegroting | € 2.499.188 |
Tijdlijn
Startdatum | 1-10-2023 |
Einddatum | 30-9-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLINpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Negative Regulation of Inflammatory Responses Revealed with Camelid NanobodiesThe project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses. | ERC Consolid... | € 1.997.828 | 2024 | Details |
Architecture of Peripheral Neuroimmune Circuits and SynapsesThis project aims to explore neuro-ILC2 interactions in vivo using innovative labelling tools to enhance understanding of neuroimmune dynamics and their implications for tissue health and disease. | ERC Advanced... | € 3.500.000 | 2024 | Details |
Inflammatory signals of cell deathFIREALARM investigates intercellular signaling in pyroptotic inflammation to uncover mechanisms driving chronic diseases and develop strategies for reversing sterile inflammation. | ERC Consolid... | € 1.991.250 | 2023 | Details |
Role of prenatal stress-induced fetal neuro-immune rewiring in susceptibility to develop pediatric eczemaThis project investigates how prenatal stress influences the development of eczema in infants using mouse models and advanced imaging techniques to identify neuro-immune dysregulations. | ERC Consolid... | € 2.857.135 | 2024 | Details |
Network Synergies in Tissue Homeostasis and Stromal Prevention of Inflammatory Disease.This project aims to uncover the mechanisms of tissue homeostasis and stromal biology to prevent inflammation onset, using advanced bioimaging and computational techniques for therapeutic advancements. | ERC Starting... | € 1.499.514 | 2022 | Details |
Negative Regulation of Inflammatory Responses Revealed with Camelid Nanobodies
The project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses.
Architecture of Peripheral Neuroimmune Circuits and Synapses
This project aims to explore neuro-ILC2 interactions in vivo using innovative labelling tools to enhance understanding of neuroimmune dynamics and their implications for tissue health and disease.
Inflammatory signals of cell death
FIREALARM investigates intercellular signaling in pyroptotic inflammation to uncover mechanisms driving chronic diseases and develop strategies for reversing sterile inflammation.
Role of prenatal stress-induced fetal neuro-immune rewiring in susceptibility to develop pediatric eczema
This project investigates how prenatal stress influences the development of eczema in infants using mouse models and advanced imaging techniques to identify neuro-immune dysregulations.
Network Synergies in Tissue Homeostasis and Stromal Prevention of Inflammatory Disease.
This project aims to uncover the mechanisms of tissue homeostasis and stromal biology to prevent inflammation onset, using advanced bioimaging and computational techniques for therapeutic advancements.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
SKIN MICROBIAL DEVICESSKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering. | EIC Pathfinder | € 1.718.408 | 2023 | Details |
Revolutionizing Skin Health with our Advanced Engineered BiotherapeuticsThe SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization. | EIC Transition | € 2.499.999 | 2025 | Details |
SKIN MICROBIAL DEVICES
SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.
Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics
The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.